RxDoctor Payments Data

Joel Adams

General Practice · Russell, KSNPI 1548614118

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 40.6% of the total. Among general practice clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,727in general payments, 2019–2025

Across 202 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$439
  • Johnson & Johnson$333
  • GSK$282
  • Sanofi$242
  • Novartis$208
  • plus $709 from 18 others

What the payments were for

  • Food & beverage$3,64998%
  • Education$782%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,727 in reported general payments places this provider in the 90th percentile of 771 general practice providers in Kansas.

See all general practice providers in Kansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
RinvoqUpadacitinib20$205,588
Enbrel SureclickEtanercept25$197,549
Xeljanz XrTofacitinib Citrate12$69,137
Hydroxychloroquine Sulfate296$8,149
MethotrexateMethotrexate Sodium233$3,324
Leflunomide53$2,343
Mycophenolate Mofetil19$1,774
Azathioprine60$1,423
Celecoxib44$1,055
Prednisone173$930
Sulfasalazine DrSulfasalazine29$885
Sulfasalazine47$872
Gabapentin47$842
Doxycycline Hyclate48$741
Diclofenac Sodium30$571

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$1,515$205,58820 claims
Scilex Pharmaceuticals Inc.Colchicine$68$45211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 771 general practice providers in Kansas.

Other general practice in Russell

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →